Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 69.66
-2.34 (-3.25%)
Mar 4, 2026, 4:26 PM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 27.18 million as of March 4, 2026. Its market cap has increased by 37.14% in one year.
Market Cap
27.18M
Enterprise Value
25.47M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
69.66
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 27.18M, a decrease of -59.42%. That is a compound annual growth rate of -17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 27.18M | -10.56% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 67.15M |
| Hemogenyx Pharmaceuticals | 60.33M |
| hVIVO | 55.11M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 34.94M |
| Poolbeg Pharma | 29.61M |
| SkinBioTherapeutics | 24.78M |
| Aptamer Group | 22.92M |